Bluebird Total Assets vs Long Term Debt Total Analysis

BLUE Stock

USD 0.92 0.01 1.10%

Bluebird Bio financial indicator trend analysis is way more than just evaluating Bluebird bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bluebird bio is a good investment. Please check the relationship between Bluebird Bio Total Assets and its Long Term Debt Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Total Assets vs Long Term Debt Total

Total Assets vs Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bluebird bio Total Assets account and Long Term Debt Total. At this time, the significance of the direction appears to have strong relationship.

The correlation between Bluebird Bio's Total Assets and Long Term Debt Total is 0.65. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of Bluebird bio, assuming nothing else is changed. The correlation between historical values of Bluebird Bio's Total Assets and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Bluebird bio are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Total Assets i.e., Bluebird Bio's Total Assets and Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.65

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Assets

Total assets refers to the total amount of Bluebird Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bluebird bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Long Term Debt Total

Most indicators from Bluebird Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bluebird bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.At present, Bluebird Bio's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 386.4 M, whereas Discontinued Operations is forecasted to decline to (242.6 M).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	529.9M	275.7M	157.9M	150.0M
Cost Of Revenue	38.9M	10.1M	23.9M	35.5M

Total Operating Expenses Cost Of Revenue

Bluebird Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Total Assets		0.7	0.7	0.96	0.7	0.67	0.56	-0.42	-0.27	0.51	0.76	0.86	0.6	0.6	0.94	0.55	0.36	0.93	0.6	0.58	0.54	0.7	0.63	0.94	0.06	0.46
Other Current Liab	0.7		0.95	0.6	0.31	0.75	0.21	0.01	-0.69	0.83	0.35	0.71	0.92	0.92	0.63	0.71	0.67	0.7	0.59	0.87	0.77	0.83	0.74	0.61	0.15	0.6
Total Current Liabilities	0.7	0.95		0.58	0.33	0.86	0.2	0.08	-0.78	0.93	0.35	0.77	0.98	0.98	0.58	0.86	0.79	0.66	0.69	0.82	0.86	0.92	0.85	0.58	0.39	0.75
Total Stockholder Equity	0.96	0.6	0.58		0.79	0.47	0.67	-0.6	-0.07	0.38	0.82	0.78	0.47	0.47	0.99	0.45	0.22	0.95	0.47	0.54	0.34	0.57	0.42	0.98	-0.15	0.25
Other Liab	0.7	0.31	0.33	0.79		0.2	0.62	-0.5	0.23	0.15	0.53	0.62	0.22	0.22	0.73	0.18	-0.11	0.81	0.22	0.49	-0.01	0.3	0.15	0.72	-0.14	-0.03
Property Plant And Equipment Net	0.67	0.75	0.86	0.47	0.2		0.03	0.29	-0.79	0.81	0.27	0.76	0.87	0.87	0.45	0.79	0.78	0.52	0.87	0.55	0.91	0.94	1.0	0.46	0.64	0.86
Current Deferred Revenue	0.56	0.21	0.2	0.67	0.62	0.03		-0.78	0.27	0.03	0.78	0.28	0.02	0.03	0.71	0.12	-0.2	0.56	-0.06	0.16	-0.08	0.07	-0.01	0.69	-0.44	-0.05
Net Debt	-0.42	0.01	0.08	-0.6	-0.5	0.29	-0.78		-0.53	0.24	-0.83	0.0	0.24	0.24	-0.63	0.14	0.41	-0.44	0.25	-0.07	0.36	0.18	0.33	-0.67	0.64	0.37
Retained Earnings	-0.27	-0.69	-0.78	-0.07	0.23	-0.79	0.27	-0.53		-0.79	0.06	-0.48	-0.83	-0.83	-0.07	-0.84	-0.91	-0.12	-0.59	-0.48	-0.94	-0.74	-0.82	-0.06	-0.68	-0.91
Accounts Payable	0.51	0.83	0.93	0.38	0.15	0.81	0.03	0.24	-0.79		0.19	0.66	0.95	0.95	0.38	0.81	0.82	0.47	0.7	0.67	0.82	0.88	0.81	0.38	0.48	0.73
Cash	0.76	0.35	0.35	0.82	0.53	0.27	0.78	-0.83	0.06	0.19		0.39	0.21	0.21	0.84	0.33	0.07	0.64	0.24	0.27	0.18	0.32	0.24	0.89	-0.22	0.17
Non Current Assets Total	0.86	0.71	0.77	0.78	0.62	0.76	0.28	0.0	-0.48	0.66	0.39		0.74	0.74	0.74	0.7	0.6	0.84	0.73	0.58	0.68	0.82	0.74	0.69	0.33	0.61
Non Currrent Assets Other	0.6	0.92	0.98	0.47	0.22	0.87	0.02	0.24	-0.83	0.95	0.21	0.74		1.0	0.46	0.85	0.86	0.57	0.76	0.79	0.87	0.94	0.87	0.46	0.46	0.76
Other Assets	0.6	0.92	0.98	0.47	0.22	0.87	0.03	0.24	-0.83	0.95	0.21	0.74	1.0		0.46	0.85	0.86	0.57	0.75	0.79	0.88	0.94	0.87	0.46	0.46	0.76
Cash And Short Term Investments	0.94	0.63	0.58	0.99	0.73	0.45	0.71	-0.63	-0.07	0.38	0.84	0.74	0.46	0.46		0.41	0.21	0.94	0.46	0.53	0.33	0.56	0.41	0.99	-0.23	0.21
Common Stock Total Equity	0.55	0.71	0.86	0.45	0.18	0.79	0.12	0.14	-0.84	0.81	0.33	0.7	0.85	0.85	0.41		0.91	0.42	0.64	0.56	0.88	0.81	0.8	0.42	0.59	0.89
Common Stock Shares Outstanding	0.36	0.67	0.79	0.22	-0.11	0.78	-0.2	0.41	-0.91	0.82	0.07	0.6	0.86	0.86	0.21	0.91		0.25	0.74	0.45	0.9	0.83	0.81	0.2	0.63	0.85
Short Term Investments	0.93	0.7	0.66	0.95	0.81	0.52	0.56	-0.44	-0.12	0.47	0.64	0.84	0.57	0.57	0.94	0.42	0.25		0.53	0.68	0.37	0.65	0.48	0.92	-0.12	0.22
Non Current Liabilities Total	0.6	0.59	0.69	0.47	0.22	0.87	-0.06	0.25	-0.59	0.7	0.24	0.73	0.76	0.75	0.46	0.64	0.74	0.53		0.39	0.71	0.92	0.86	0.46	0.49	0.61
Other Current Assets	0.58	0.87	0.82	0.54	0.49	0.55	0.16	-0.07	-0.48	0.67	0.27	0.58	0.79	0.79	0.53	0.56	0.45	0.68	0.39		0.54	0.65	0.52	0.54	0.13	0.39
Other Stockholder Equity	0.54	0.77	0.86	0.34	-0.01	0.91	-0.08	0.36	-0.94	0.82	0.18	0.68	0.87	0.88	0.33	0.88	0.9	0.37	0.71	0.54		0.85	0.93	0.33	0.66	0.95
Total Liab	0.7	0.83	0.92	0.57	0.3	0.94	0.07	0.18	-0.74	0.88	0.32	0.82	0.94	0.94	0.56	0.81	0.83	0.65	0.92	0.65	0.85		0.93	0.56	0.48	0.74
Property Plant And Equipment Gross	0.63	0.74	0.85	0.42	0.15	1.0	-0.01	0.33	-0.82	0.81	0.24	0.74	0.87	0.87	0.41	0.8	0.81	0.48	0.86	0.52	0.93	0.93		0.42	0.67	0.88
Total Current Assets	0.94	0.61	0.58	0.98	0.72	0.46	0.69	-0.67	-0.06	0.38	0.89	0.69	0.46	0.46	0.99	0.42	0.2	0.92	0.46	0.54	0.33	0.56	0.42		-0.19	0.23
Short Term Debt	0.06	0.15	0.39	-0.15	-0.14	0.64	-0.44	0.64	-0.68	0.48	-0.22	0.33	0.46	0.46	-0.23	0.59	0.63	-0.12	0.49	0.13	0.66	0.48	0.67	-0.19		0.78
Common Stock	0.46	0.6	0.75	0.25	-0.03	0.86	-0.05	0.37	-0.91	0.73	0.17	0.61	0.76	0.76	0.21	0.89	0.85	0.22	0.61	0.39	0.95	0.74	0.88	0.23	0.78

Click cells to compare fundamentals

Bluebird Bio Account Relationship Matchups

Bluebird Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.7B	1.8B	593.8M	554.9M	638.1M	1.1B
Other Current Liab	141.6M	145.4M	101.7M	50.5M	58.1M	55.2M
Total Current Liabilities	223.6M	203.6M	153.0M	128.2M	147.5M	105.5M
Total Stockholder Equity	1.3B	1.4B	374.3M	196.3M	225.8M	214.5M
Other Liab	58.0M	48.0M	54.6M	93K	107.0K	101.6K
Property Plant And Equipment Net	337.1M	346.9M	101.2M	291.4M	335.1M	351.8M
Current Deferred Revenue	18.9M	11.6M	2.3M	1.5M	1.4M	1.3M
Net Debt	(136.2M)	(124.7M)	(71.6M)	168.4M	193.6M	203.3M
Retained Earnings	(2.3B)	(2.9B)	(3.7B)	(4.0B)	(3.6B)	(3.4B)
Accounts Payable	43.0M	21.6M	25.9M	25.1M	28.9M	16.3M
Cash	327.2M	317.7M	161.2M	113.0M	130.0M	123.5M
Non Current Assets Total	575.3M	565.7M	257.3M	355.4M	408.7M	350.9M
Non Currrent Assets Other	79.2M	72.8M	53.3M	52.1M	59.9M	33.0M
Other Assets	79.2M	72.8M	53.3M	52.1M	59.9M	33.2M
Cash And Short Term Investments	1.2B	1.3B	396.6M	181.7M	209.0M	198.6M
Common Stock Total Equity	547K	554K	665K	711K	817.7K	431.4K
Common Stock Shares Outstanding	55.2M	62.2M	68.9M	78.6M	90.4M	47.4M
Short Term Investments	779.2M	833.5M	138.3M	67.3M	77.4M	73.5M
Liabilities And Stockholders Equity	1.7B	1.8B	593.8M	554.9M	638.1M	1.1B
Non Current Liabilities Total	218.9M	222.6M	66.5M	230.3M	264.9M	154.1M
Other Current Assets	45.7M	64.3M	37.0M	8.4M	9.6M	9.1M
Other Stockholder Equity	3.6B	4.3B	4.1B	4.2B	4.8B	5.1B
Total Liab	442.4M	426.2M	219.5M	358.6M	412.3M	259.6M
Property Plant And Equipment Gross	337.1M	346.9M	121.6M	313.3M	360.3M	378.3M
Total Current Assets	1.2B	1.2B	336.5M	199.5M	229.4M	217.9M
Accumulated Other Comprehensive Income	(1.9M)	(5.5M)	(2.9M)	(4.1M)	(3.7M)	(3.8M)
Short Term Debt	20.2M	25.0M	23.2M	51.2M	58.8M	61.8M
Common Stock	554K	665K	711K	830K	954.5K	1.0M
Property Plant Equipment	151.2M	162.8M	101.2M	291.4M	335.1M	351.8M
Net Tangible Assets	1.3B	1.3B	368.6M	185.8M	213.7M	203.0M
Net Receivables	12.8M	26.8M	11.4M	10.8M	12.4M	11.0M
Retained Earnings Total Equity	(1.5B)	(2.3B)	(2.9B)	(3.7B)	(3.3B)	(3.2B)
Capital Surpluse	3.4B	3.6B	4.3B	4.1B	4.7B	2.6B
Inventory	(144.3M)	(149.7M)	(108.5M)	(1.4M)	(1.3M)	(1.3M)
Non Current Liabilities Other	218.9M	222.6M	93K	92K	105.8K	100.5K
Intangible Assets	14.3M	10.0M	5.6M	4.9M	4.4M	4.2M
Long Term Investments	131.5M	122.9M	97.1M	1.4M	1.3M	1.2M

Pair Trading with Bluebird Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bluebird Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bluebird Stock

0.61

DRRX

Durect Earnings Call This Week

Pair Corr

Moving against Bluebird Stock

0.49

ACB

Aurora Cannabis Sell-off Trend

Pair Corr

The ability to find closely correlated positions to Bluebird Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bluebird Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bluebird Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bluebird bio to buy it.

The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bluebird Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bluebird bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bluebird Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:

How To Invest In Bluebird

Details

Is Bluebird Stock a good investment?

Details

What is Bluebird Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.

	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.63)

Revenue Per Share

0.214

Quarterly Revenue Growth

173.535

Return On Assets

(0.15)

Return On Equity

(0.48)

The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bluebird Total Assets vs Long Term Debt Total Analysis

Total Assets vs Long Term Debt Total

Total Assets vs Long Term Debt Total Correlation Analysis

Correlation Coefficient

Total Assets

Long Term Debt Total

Bluebird Bio fundamental ratios Correlations

Bluebird Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bluebird Bio fundamental ratios Accounts

Pair Trading with Bluebird Bio

Moving together with Bluebird Stock

Moving against Bluebird Stock

Complementary Tools for Bluebird Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Other Assets	+ 1.0	Non Currrent Assets Other
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Cash And Short Term Investments
Non Currrent Assets Other	+ 0.98	Total Current Liabilities
Other Assets	+ 0.98	Total Current Liabilities

Other Stockholder Equity	- 0.94	Retained Earnings
Common Stock	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.91	Retained Earnings
Common Stock Total Equity	- 0.84	Retained Earnings
Other Assets	- 0.83	Retained Earnings
Non Currrent Assets Other	- 0.83	Retained Earnings